In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.

@article{Hanafy2007InvitroAA,
  title={In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.},
  author={Ahmed Hanafy and Jun Uno and Hiroki Mitani and Yingqian Kang and Yuzuru Mikami},
  journal={Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology},
  year={2007},
  volume={48 1},
  pages={47-50}
}
In vitro susceptibilities of ten clinical isolates, including five strains of Cryptococcus neoformans var. grubii and five strains of Aspergillus fumigatus, were determined against nine sulfa drugs using a microdilution method. Among the five tested media, minimum inhibitory concentration (MIC) values were observed only in YNB medium: no detectable level MIC value of less than 125 microg/ml was observed in the four remaining media against Cryptococcus species. Of the nine sulfa drugs, of which… CONTINUE READING